Applied Molecular Transport Inc. (AMTI): Price and Financial Metrics

Applied Molecular Transport Inc. (AMTI): $0.63

0.02 (+3.09%)

POWR Rating

Component Grades













Add AMTI to Watchlist
Sign Up

Industry: Biotech



in industry

AMTI Stock Price Chart Interactive Chart >

Price chart for AMTI

AMTI Price/Volume Stats

Current price $0.63 52-week high $10.42
Prev. close $0.61 52-week low $0.33
Day low $0.62 Volume 96,081
Day high $0.66 Avg. volume 205,324
50-day MA $0.80 Dividend yield N/A
200-day MA $1.95 Market Cap 24.53M

Applied Molecular Transport Inc. (AMTI) Company Bio

Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood and Randall J. Mrsny on November 21, 2016 and is headquartered in South San Francisco, CA.

AMTI Latest News Stream

Event/Time News Detail
Loading, please wait...

AMTI Latest Social Stream

Loading social stream, please wait...

View Full AMTI Social Stream

Latest AMTI News From Around the Web

Below are the latest news stories about APPLIED MOLECULAR TRANSPORT INC that investors may wish to consider to help them evaluate AMTI as an investment opportunity.

Should This Make Applied Molecular Transport Inc. (NASDAQ: AMTI) Investors Worry?

The trading price of Applied Molecular Transport Inc. (NASDAQ:AMTI) closed lower on Tuesday, December 27, closing at $0.37, -14.11% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.36 and $0.4495. In examining the 52-week price action we see that the stock hit a … Should This Make Applied Molecular Transport Inc. (NASDAQ: AMTI) Investors Worry? Read More »

Stocks Register | December 28, 2022

Applied Molecular Transport Inc. (AMTI) can beat the pack with these strategies

As of Friday, Applied Molecular Transport Inc.’s (NASDAQ:AMTI) stock closed at $0.44, down from $1.03 the previous day. While Applied Molecular Transport Inc. has underperformed by -57.77%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMTI fell by -97.01%, with highs and lows ranging from $14.94 […]

US Post News | December 27, 2022

AMTI stock drops as JMP downgrades on trial setback (NASDAQ:AMTI)

Applied Molecular Transport (AMTI) lost ~16% pre-market Friday after JMP Securities downgraded it to Market Perform citing a clinical trial setback. Read the full story here.

Seeking Alpha | December 23, 2022

Applied Molecular's Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients

Applied Molecular Transport Inc (NASDAQ: AMTI) announced topline Phase 2 results from the LOMBARD monotherapy trial for AMT-101 in biologic-naïve and experienced patients with moderate-to-severe ulcerative colitis (UC). The clinical remission (CR) rate in patients treated with AMT-101 monotherapy was 17.1% (12/70 patients) compared to a CR rate of 20.0% (7/35 patients) with placebo, which was above the company's baseline assumption for placebo CR rates based on published data in moderate-to-seve

Yahoo | December 23, 2022

Stocks to Watch: iMedia Brands, Centogene, Applied Molecular Transport

By Denny Jacob iMedia Brands Inc. said it is selling three buildings for $48 million to reduce its debt position. Shares surged 26% in after-hours trading….

MarketWatch | December 22, 2022

Read More 'AMTI' Stories Here

AMTI Price Returns

1-mo 50.00%
3-mo -28.25%
6-mo -67.36%
1-year -93.31%
3-year N/A
5-year N/A
YTD 50.00%
2022 -97.00%
2021 -54.57%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5822 seconds.